AIGH Capital Management LLC - Q1 2021 holdings

$475 Million is the total value of AIGH Capital Management LLC's 93 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 113.3% .

 Value Shares↓ Weighting
IWM NewISHARES TRput$132,564,000600,000
+100.0%
27.89%
COHU BuyCOHU INC$27,859,000
+25.8%
665,853
+14.8%
5.86%
-34.8%
IWO NewISHARES TRput$23,977,000100,000
+100.0%
5.04%
AVNW BuyAVIAT NETWORKS INC$19,702,000
+871.5%
277,341
+367.0%
4.14%
+403.0%
EMKR BuyEMCORE CORP$18,401,000
+46.1%
3,370,153
+45.9%
3.87%
-24.3%
OIIM  O2MICRO INTERNATIONAL LIMITEspons adr$14,297,000
-14.8%
1,828,1990.0%3.01%
-55.9%
FKWL NewFRANKLIN WIRELESS CORP$13,947,000780,000
+100.0%
2.93%
THTX BuyTHERATECHNOLOGIES INC$13,820,000
+858.4%
3,575,733
+519.9%
2.91%
+396.2%
ASPN  ASPEN AEROGELS INC$13,340,000
+21.9%
655,8190.0%2.81%
-36.9%
DZSI NewDZS INC$11,257,000723,923
+100.0%
2.37%
ADMS BuyADAMAS PHARMACEUTICALS INC$10,611,000
+179.8%
2,210,743
+152.4%
2.23%
+44.9%
RMNI NewRIMINI STR INC DEL$10,550,0001,176,084
+100.0%
2.22%
AVYA SellAVAYA HLDGS CORP$10,091,000
-20.2%
360,000
-45.5%
2.12%
-58.6%
NewISHARES TRput$9,963,000410,000
+100.0%
2.10%
PBW NewINVESCO EXCHANGE TRADED FD Tput$9,839,000100,000
+100.0%
2.07%
PBYI NewPUMA BIOTECHNOLOGY INC$9,376,000964,590
+100.0%
1.97%
EDAP BuyEDAP TMS S Asponsored adr$9,099,000
+341.1%
1,083,250
+171.6%
1.91%
+128.4%
AVYA NewAVAYA HLDGS CORPcall$8,409,000300,000
+100.0%
1.77%
GRTX NewGALERA THERAPEUTICS INC$8,050,000912,599
+100.0%
1.69%
NVVE NewNUVVE HOLDING CORP$7,622,000800,000
+100.0%
1.60%
BWAY NewBRAINSWAY LTDsponsored ads$6,863,000760,000
+100.0%
1.44%
SBBP BuySTRONGBRIDGE BIOPHARMA PLC$6,056,000
+41.3%
2,194,173
+24.4%
1.27%
-26.9%
LPTH  LIGHTPATH TECHNOLOGIES INC$5,749,000
-20.9%
1,854,3240.0%1.21%
-59.0%
SCPH BuySCPHARMACEUTICALS INC$5,686,000
+68.6%
855,142
+34.2%
1.20%
-12.7%
ALNA BuyALLENA PHARMACEUTICALS$5,560,000
+117.2%
4,000,000
+100.0%
1.17%
+12.5%
INFI NewINFINITY PHARMACEUTICALS INC$5,330,0001,650,256
+100.0%
1.12%
PRTK  PARATEK PHARMACEUTICALS INC$5,292,000
+12.8%
749,6080.0%1.11%
-41.6%
 ALIMERA SCIENCES INC$4,820,000
+128.0%
501,0250.0%1.01%
+18.0%
YTEN NewYIELD10 BIOSCIENCE INC$4,765,000380,000
+100.0%
1.00%
MYO SellMYOMO INC$4,568,000
+56.5%
356,925
-17.7%
0.96%
-18.9%
TLND NewTALEND S Aads$4,188,00065,800
+100.0%
0.88%
PCSA NewPROCESSA PHARMACEUTICALS INC$4,008,000387,097
+100.0%
0.84%
MDNA NewMEDICENNA THERAPEUTICS CORP$3,427,000840,000
+100.0%
0.72%
ANVS SellANNOVIS BIO INC$3,101,000
-11.3%
117,256
-74.7%
0.65%
-54.1%
NewCHF SOLUTIONS INC$2,955,000500,000
+100.0%
0.62%
HJLI NewHANCOCK JAFFE LABORATORIES I$2,855,000428,570
+100.0%
0.60%
SLRX BuySALARIUS PHARMACEUTICALS INC$2,664,000
+94.5%
1,800,000
+19.5%
0.56%
+0.7%
EVOK NewEVOKE PHARMA INC$2,623,0001,433,113
+100.0%
0.55%
ARDS BuyARIDIS PHARMACEUTICALS INC$2,495,000
+18.4%
423,357
+22.0%
0.52%
-38.7%
EXFO NewEXFO INC$2,226,000522,492
+100.0%
0.47%
DAIO BuyDATA I O CORP$2,051,000
+150.1%
378,310
+90.3%
0.43%
+29.7%
HSDT NewHELIUS MED TECHNOLOGIES INC$1,821,000101,214
+100.0%
0.38%
HTGM NewHTG MOLECULAR DIAGNOSTICS IN$1,269,000232,000
+100.0%
0.27%
GANX NewGAIN THERAPEUTICS INC$982,00065,809
+100.0%
0.21%
BLIN NewBRIDGELINE DIGITAL INC$512,000177,419
+100.0%
0.11%
EYEN NewEYENOVIA INC$408,00079,807
+100.0%
0.09%
CYTH SellCYCLO THERAPEUTICS INC$141,000
-90.7%
17,235
-95.1%
0.03%
-95.2%
VLON NewVALLON PHARMACEUTICALS INC$95,00020,514
+100.0%
0.02%
VUZI ExitVUZIX CORP$0-26,159
-100.0%
-0.10%
PBLA ExitPANBELA THERAPEUTICS INC$0-89,730
-100.0%
-0.13%
KTCC ExitKEY TRONIC CORP$0-47,353
-100.0%
-0.13%
ACER ExitACER THERAPEUTICS INC$0-250,518
-100.0%
-0.27%
NDRA ExitENDRA LIFE SCIENCES INC$0-1,300,000
-100.0%
-0.40%
EFOI ExitENERGY FOCUS INC$0-279,535
-100.0%
-0.46%
CLRBZ ExitCELLECTAR BIOSCIENCES INC*w exp 04/20/202$0-583,037
-100.0%
-0.50%
CYTHW ExitCYCLO THERAPEUTICS INC*w exp 11/14/202$0-350,000
-100.0%
-0.62%
PXLW ExitPIXELWORKS INC$0-667,120
-100.0%
-0.76%
HEPA ExitHEPION PHARMACEUTICALS INC$0-923,230
-100.0%
-0.82%
RIGL ExitRIGEL PHARMACEUTICALS INC$0-701,700
-100.0%
-1.00%
CBIO ExitCATALYST BIOSCIENCES INC$0-421,042
-100.0%
-1.08%
NMTR Exit9 METERS BIOPHARMA INC$0-3,115,000
-100.0%
-1.09%
CPRX ExitCATALYST PHARMACEUTICALS INC$0-1,350,554
-100.0%
-1.83%
VNDA ExitVANDA PHARMACEUTICALS INC$0-349,463
-100.0%
-1.86%
MIRM ExitMIRUM PHARMACEUTICALS INC$0-274,583
-100.0%
-1.95%
ExitIDEAL PWR INC$0-753,970
-100.0%
-2.50%
OBCI ExitOCEAN BIO CHEM INC$0-612,222
-100.0%
-3.32%
NLS ExitNAUTILUS INC$0-650,970
-100.0%
-4.80%
COHR ExitCOHERENT INC$0-78,808
-100.0%
-4.80%
ExitFORD MTR CO DELcall$0-1,500,000
-100.0%
-5.36%
FFIV ExitF5 NETWORKS INC$0-75,000
-100.0%
-5.36%
CLDR ExitCLOUDERA INC$0-1,000,000
-100.0%
-5.65%
BLBD ExitBLUE BIRD CORP$0-819,360
-100.0%
-6.08%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AVIAT NETWORKS INC12Q3 20236.8%
SCPHARMACEUTICALS INC12Q3 20238.5%
THERATECHNOLOGIES INC11Q2 20232.9%
FRANKLIN WIRELESS CORP11Q3 20232.9%
IDEAL PWR INC11Q3 20232.5%
MEDICENNA THERAPEUTICS CORP11Q3 20231.1%
PARATEK PHARMACEUTICALS INC10Q1 20233.2%
LIGHTPATH TECHNOLOGIES INC10Q3 20233.0%
MYOMO INC10Q3 20231.3%
DZS INC9Q1 20237.5%

View AIGH Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
AIGH Capital Management LLC Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bridgeline Digital, Inc.May 21, 2021627,4199.7%

View AIGH Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-15
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-11-12

View AIGH Capital Management LLC's complete filings history.

Compare quarters

Export AIGH Capital Management LLC's holdings